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Editorial
Pancreatic cancer is the second most common cause of
cancer death among all gastrointestinal cancers. It contin-
ues to be a devastating disease and only a limited number
of patients can be cured. Within the last decade there was
truly significant progress in understanding basic cellular
and molecular pathways which influence the course of
this disease. Therefore, there are reasons to believe that
these advances in molecular research represent on of the
most likely resource from which significant improve-
ments in the management of pancreatic cancer are to
come for the future.
Thus we compelled a series of reviews which highlight the
most important issues in local and systemic growth of
pancreatic cancer. New transgenic models of pancreatic
cancer (may) open new horizons in understanding and
interfering pancreatic cancer development. Pancreatic car-
cinogenesis is a process with numerous genetic alterations
and general chromosome instability, both issues to be re-
viewed in this special issue. Furthermore, the impact of
growth factors, their receptors and some of the most
promising pathways for therapy are highlighted. Novel in-
sight in apoptotic pathways and possible therapeutic in-
terventions are discussed. The role of tumor
neoangiogenesis and the relation to the tumor microenvi-
ronment, alterations in angiogenic pathways and the role
of the endocrine pancreas are also discussed comprehen-
sively. In addition, the value of possible novel markers in
diagnosis of pancreatic cancer are being reviewed.
Thus it was possible to cover many of the most important
aspects of molecular pathogenesis, diagnosis and therapy
of pancreatic cancer. This molecular approach was created
in an effort to reflect the current state of the art in the area
of pancreatic cancer, with outstanding contributions from
renowned experts in this field. Therefore, this issue should
be of interest for all basic and clinical pancreatologists
who work in this challenging area. Last but not least, it is
our particular pleasure to thank all contributors for their
efforts in supporting this special issue on pancreatic can-
cer.
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